Fresenius Kabi USA, LLC v. Natco Pharma USA LLC
1:24-cv-00472
Overview
Parties
Counter Claimant
Natco Pharma USA LLC Operating Company
Represented By
4 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Counter Defendant
Fresenius Kabi Deutschland GmbH Operating Company
Represented By
10 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Shaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Fresenius Kabi USA, LLC Operating Company
Represented By
10 Attorneys ListedShaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Shaw Keller LLP
1105 North Market Street, 12th Floor, Wilmington, DE 19801
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | Asserted Patent | View Official Patent → |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9731082
Drug container
|
Filed: 2008-12-02
Issued: 2017-08-15
|
Active (5.4 yrs remaining)
+1238d PTA
Expires: 2032-04-23
|
|
|
US10661018
Drug container
|
Filed: 2017-08-07
Issued: 2020-05-26
|
Active (2.7 yrs remaining)
Expires: 2029-07-26
|
|
|
US11426522
Drug container
|
Filed: 2020-05-21
Issued: 2022-08-30
|
Active (2.7 yrs remaining)
Expires: 2029-07-16
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
High PTA (+1238 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
6
Dispositive
0
Granted
0
Denied
0
Pending / Review
6
Motions by Category
Key Dispositive Motions & Rulings